Indofarma | Cash Flow

Fiscal year is January-December. All values IDR Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
54,222
-
-
-
-
288
Other Funds
-
148,346
127,910
-
-
288
Funds from Operations
140,852
149,787
134,477
317,263
147,586
70,103
Net Operating Cash Flow
140,852
149,787
134,477
317,263
147,586
70,103
Capital Expenditures
36,608
56,048
22,954
59,635
94,874
Sale of Fixed Assets & Businesses
-
600
3,038
-
973
Net Investing Cash Flow
36,608
55,448
19,916
59,635
93,901
Cash Dividends Paid - Total
4,239
-
-
-
-
Issuance/Reduction of Debt, Net
123,199
79,747
62,175
120,157
72,967
Net Financing Cash Flow
118,960
79,747
62,175
120,157
72,967
Net Change in Cash
73,471
14,323
177,718
257,239
126,354
Free Cash Flow
172,953
102,051
118,146
350,548
69,501
Exchange Rate Effect
14,970
270
982
498
298

About Indofarma

View Profile
Address
Jalan Indofarma No. 1 Gandasari
Bekasi JB 17530
Indonesia
Employees -
Website http://www.indofarma.co.id
Updated 07/08/2019
PT Indofarma (Persero) Tbk engages in the pharmaceutical and healthcare businesses. It operates through the following segments: Medicine, Medical Devices & Others, and Pharmaceutical Engineering. The company was founded in 1918 and is headquartered in Bekasi, Indonesia.